These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 19357831)

  • 1. Role of atypical protein kinase C in activation of sterol regulatory element binding protein-1c and nuclear factor kappa B (NFkappaB) in liver of rodents used as a model of diabetes, and relationships to hyperlipidaemia and insulin resistance.
    Sajan MP; Standaert ML; Rivas J; Miura A; Kanoh Y; Soto J; Taniguchi CM; Kahn CR; Farese RV
    Diabetologia; 2009 Jun; 52(6):1197-207. PubMed ID: 19357831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The critical role of atypical protein kinase C in activating hepatic SREBP-1c and NFkappaB in obesity.
    Sajan MP; Standaert ML; Nimal S; Varanasi U; Pastoor T; Mastorides S; Braun U; Leitges M; Farese RV
    J Lipid Res; 2009 Jun; 50(6):1133-45. PubMed ID: 19202134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insulin-sensitive protein kinases (atypical protein kinase C and protein kinase B/Akt): actions and defects in obesity and type II diabetes.
    Farese RV; Sajan MP; Standaert ML
    Exp Biol Med (Maywood); 2005 Oct; 230(9):593-605. PubMed ID: 16179727
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combined thiazolidinedione-metformin treatment synergistically improves insulin signalling to insulin receptor substrate-1-dependent phosphatidylinositol 3-kinase, atypical protein kinase C and protein kinase B/Akt in human diabetic muscle.
    Temofonte N; Sajan MP; Nimal S; Pastoor T; Fumero C; Casaubon L; Powe JL; Standaert ML; Farese RV
    Diabetologia; 2009 Jan; 52(1):60-4. PubMed ID: 18972094
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-induced activation of atypical protein kinase C, but not protein kinase B, is maintained in diabetic (ob/ob and Goto-Kakazaki) liver. Contrasting insulin signaling patterns in liver versus muscle define phenotypes of type 2 diabetic and high fat-induced insulin-resistant states.
    Standaert ML; Sajan MP; Miura A; Kanoh Y; Chen HC; Farese RV; Farese RV
    J Biol Chem; 2004 Jun; 279(24):24929-34. PubMed ID: 15069067
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated regulation of hepatic FoxO1, PGC-1α and SREBP-1c facilitates insulin action and resistance.
    Sajan MP; Lee MC; Foufelle F; Sajan J; Cleland C; Farese RV
    Cell Signal; 2018 Mar; 43():62-70. PubMed ID: 29269047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role for sterol regulatory element binding protein-1c activation in mediating skeletal muscle insulin resistance via repression of rat insulin receptor substrate-1 transcription.
    Bi Y; Wu W; Shi J; Liang H; Yin W; Chen Y; Tang S; Cao S; Cai M; Shen S; Gao Q; Weng J; Zhu D
    Diabetologia; 2014 Mar; 57(3):592-602. PubMed ID: 24362725
    [TBL] [Abstract][Full Text] [Related]  

  • 8. GRP78 expression inhibits insulin and ER stress-induced SREBP-1c activation and reduces hepatic steatosis in mice.
    Kammoun HL; Chabanon H; Hainault I; Luquet S; Magnan C; Koike T; Ferré P; Foufelle F
    J Clin Invest; 2009 May; 119(5):1201-15. PubMed ID: 19363290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Tissue-specific differences in activation of atypical protein kinase C and protein kinase B in muscle, liver, and adipocytes of insulin receptor substrate-1 knockout mice.
    Sajan MP; Standaert ML; Miura A; Kahn CR; Farese RV
    Mol Endocrinol; 2004 Oct; 18(10):2513-21. PubMed ID: 15256535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metformin attenuates palmitic acid-induced insulin resistance in L6 cells through the AMP-activated protein kinase/sterol regulatory element-binding protein-1c pathway.
    Wu W; Tang S; Shi J; Yin W; Cao S; Bu R; Zhu D; Bi Y
    Int J Mol Med; 2015 Jun; 35(6):1734-40. PubMed ID: 25891779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of protein kinase C-zeta by insulin and phosphatidylinositol-3,4,5-(PO4)3 is defective in muscle in type 2 diabetes and impaired glucose tolerance: amelioration by rosiglitazone and exercise.
    Beeson M; Sajan MP; Dizon M; Grebenev D; Gomez-Daspet J; Miura A; Kanoh Y; Powe J; Bandyopadhyay G; Standaert ML; Farese RV
    Diabetes; 2003 Aug; 52(8):1926-34. PubMed ID: 12882907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Protein kinase Cbeta mediates hepatic induction of sterol-regulatory element binding protein-1c by insulin.
    Yamamoto T; Watanabe K; Inoue N; Nakagawa Y; Ishigaki N; Matsuzaka T; Takeuchi Y; Kobayashi K; Yatoh S; Takahashi A; Suzuki H; Yahagi N; Gotoda T; Yamada N; Shimano H
    J Lipid Res; 2010 Jul; 51(7):1859-70. PubMed ID: 20179320
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Soy β-conglycinin improves glucose uptake in skeletal muscle and ameliorates hepatic insulin resistance in Goto-Kakizaki rats.
    Tachibana N; Yamashita Y; Nagata M; Wanezaki S; Ashida H; Horio F; Kohno M
    Nutr Res; 2014 Feb; 34(2):160-7. PubMed ID: 24461318
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Effect of Danlou Tablets on alleviating hepatic adipogenesis, inflammatory response, and insulin resistance in db/db mice].
    Pang YF; Huang M; Li L; Zhao X; Zhang HX; Li YH
    Zhongguo Zhong Yao Za Zhi; 2022 Jun; 47(12):3320-3327. PubMed ID: 35851126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin improves atypical protein kinase C activation by insulin and phosphatidylinositol-3,4,5-(PO4)3 in muscle of diabetic subjects.
    Luna V; Casauban L; Sajan MP; Gomez-Daspet J; Powe JL; Miura A; Rivas J; Standaert ML; Farese RV
    Diabetologia; 2006 Feb; 49(2):375-82. PubMed ID: 16395615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatic insulin resistance in ob/ob mice involves increases in ceramide, aPKC activity, and selective impairment of Akt-dependent FoxO1 phosphorylation.
    Sajan MP; Ivey RA; Lee MC; Farese RV
    J Lipid Res; 2015 Jan; 56(1):70-80. PubMed ID: 25395359
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insulin substrates 1 and 2 are corequired for activation of atypical protein kinase C and Cbl-dependent phosphatidylinositol 3-kinase during insulin action in immortalized brown adipocytes.
    Miura A; Sajan MP; Standaert ML; Bandyopadhyay G; Kahn CR; Farese RV
    Biochemistry; 2004 Dec; 43(49):15503-9. PubMed ID: 15581362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correction of metabolic abnormalities in a rodent model of obesity, metabolic syndrome, and type 2 diabetes mellitus by inhibitors of hepatic protein kinase C-ι.
    Sajan MP; Nimal S; Mastorides S; Acevedo-Duncan M; Kahn CR; Fields AP; Braun U; Leitges M; Farese RV
    Metabolism; 2012 Apr; 61(4):459-69. PubMed ID: 22225955
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of transcription factor sterol regulatory element binding protein-1c in palmitate acid-induced L6 cells insulin resistance and its mechanism].
    Wu W; Bi Y; Tangsun Y; Yin W; Chen Y; Zhu D
    Zhonghua Yi Xue Za Zhi; 2015 Mar; 95(8):611-5. PubMed ID: 25917039
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docosahexaenoic acid inhibits proteolytic processing of sterol regulatory element-binding protein-1c (SREBP-1c) via activation of AMP-activated kinase.
    Deng X; Dong Q; Bridges D; Raghow R; Park EA; Elam MB
    Biochim Biophys Acta; 2015 Dec; 1851(12):1521-9. PubMed ID: 26327595
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.